Location: Kai Tak, Hong Kong
CIK: 0001782539 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value: $156M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 225,688 | $48.94M | 31.3% | $121.31 | — | COM | 48576A100 |
| ILMN | ILLUMINA INC | 119,196 | $22.35M | 14.3% | $459.88 | -56.0% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $12.97M | 8.3% | $30.00 | +15.1% | COM | 413197104 |
| — | SEAGEN INC | 47,096 | $9.064M | 5.8% | $154.22 | — | COM | 81181C104 |
| OCS | OCULIS HOLDING AG | 651,100 | $8.028M | 5.1% | $9.59 | +16.3% | ORDINARY SHARES | H5870P102 |
| — | EXSCIENTIA PLC | 859,892 | $5.091M | 3.3% | $18.64 | — | ADS | 30223G102 |
| — | IVERIC BIO INC | 111,984 | $4.405M | 2.8% | $9.62 | — | COM | 46583P102 |
| XENE | XENON PHARMACEUTICALS INC | 114,380 | $4.404M | 2.8% | $18.43 | +115.7% | COM | 98420N105 |
| — | CHINOOK THERAPEUTICS INC | 113,950 | $4.378M | 2.8% | $19.66 | — | COM | 16961L106 |
| REPL | REPLIMUNE GROUP INC | 184,739 | $4.29M | 2.7% | $18.17 | +7.5% | COM | 76029N106 |
| — | MERUS N V | 151,000 | $3.976M | 2.5% | $16.58 | — | COM | N5749R100 |
| — | SOMALOGIC INC | 1,696,558 | $3.919M | 2.5% | $12.39 | — | CLASS A COM | 83444K105 |
| ONC | BEIGENE LTD | 12,022 | $2.144M | 1.4% | $265.35 | — | SPONSORED ADR | 07725L102 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $2.034M | 1.3% | $17.30 | -73.2% | COM CL A | 753018100 |
| INCY | INCYTE CORP | 32,022 | $1.993M | 1.3% | $67.41 | -0.8% | COM | 45337C102 |
| GRTX | GALERA THERAPEUTICS INC | 613,223 | $1.913M | 1.2% | $8.13 | -63.4% | COM | 36338D108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 204,720 | $1.842M | 1.2% | $15.74 | -41.4% | COM | 483497103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 136,655 | $1.818M | 1.2% | $24.13 | -49.6% | COM | 69404D108 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $1.494M | 1.0% | $15.46 | — | COM | 097702104 |
| GERN | GERON CORP | 388,000 | $1.245M | 0.8% | $2.85 | 0.0% | COM | 374163103 |
| EXEL | EXELIXIS INC | 64,200 | $1.227M | 0.8% | $23.32 | -17.4% | COM | 30161Q104 |
| BMEA | BIOMEA FUSION INC | 40,000 | $878K | 0.6% | $8.53 | +266.9% | COM | 09077A106 |
| — | AEROVATE THERAPEUTICS INC | 47,936 | $822K | 0.5% | $29.30 | — | COM | 008064107 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $743K | 0.5% | $9.39 | — | COM | 29384C108 |
| — | EARGO INC | 147,904 | $729K | 0.5% | $4.68 | — | COM NEW | 270087208 |
| ACAD | ACADIA PHARMACEUTICALS INC | 29,984 | $718K | 0.5% | $20.11 | +10.5% | COM | 004225108 |
| — | DBV TECHNOLOGIES S A | 370,950 | $705K | 0.5% | $5.33 | — | SPONSORED ADR | 23306J101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 40,070 | $661K | 0.4% | $24.26 | -25.6% | COM | 76243J105 |
| ARGX | ARGENX SE | 1,430 | $557K | 0.4% | $355.40 | — | SPONSORED ADR | 04016X101 |
| CABA | CABALETTA BIO INC | 41,123 | $531K | 0.3% | $10.85 | 0.0% | COM | 12674W109 |
| GTLB | GITLAB INC | 6,910 | $353K | 0.2% | $44.16 | -15.8% | CLASS A COM | 37637K108 |
| — | REATA PHARMACEUTICALS INC | 3,300 | $336K | 0.2% | $101.96 | — | CL A | 75615P103 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $315K | 0.2% | $60.98 | -89.3% | COM | 00166B105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,615 | $313K | 0.2% | $85.74 | +9.8% | COM | 09061G101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,182 | $273K | 0.2% | $97.80 | +176.9% | COM | 558868105 |
| — | AFFIMED N V | 372,472 | $223K | 0.1% | $1.92 | — | COM | N01045108 |
| — | AKERO THERAPEUTICS INC | 4,425 | $207K | 0.1% | $46.69 | — | COM | 00973Y108 |
| — | FIBROGEN INC | 62,106 | $168K | 0.1% | $9.06 | — | COM | 31572Q808 |
| KOD | KODIAK SCIENCES INC | 19,622 | $135K | 0.1% | $81.98 | -92.5% | COM | 50015M109 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 17,847 | $126K | 0.1% | $9.63 | -16.6% | COM | 09058V103 |
| ABCL | ABCELLERA BIOLOGICS INC | 12,521 | $80,886 | 0.1% | $15.18 | -55.0% | COM | 00288U106 |
| CERS | CERUS CORP | 14,172 | $34,863 | 0.0% | $5.54 | -57.1% | COM | 157085101 |
| — | ATHIRA PHARMA INC | 11,769 | $34,719 | 0.0% | $2.95 | — | COM | 04746L104 |